Published in Drug Metab Dispos on September 10, 2013
Enzymatic and Free Radical Formation of Cis- and Trans- Epoxyeicosatrienoic Acids In Vitro and In Vivo. Free Radic Biol Med (2017) 0.75
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem (1964) 24.57
P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev (2002) 6.14
Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol (2006) 3.27
Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res (2004) 2.98
Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem (1996) 2.95
Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A (1991) 2.75
Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem (1997) 1.92
Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch (2010) 1.77
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics (2007) 1.59
Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J (2010) 1.48
Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. Trends Pharmacol Sci (2006) 1.28
Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther (2002) 1.26
Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos (2007) 1.25
CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol (1997) 1.15
Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans (2010) 1.14
Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J Physiol (2001) 1.14
Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions. Curr Drug Metab (2006) 1.13
Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: ligand stabilization and processing of the N-terminus and heme prosthetic group. Arch Biochem Biophys (2003) 1.13
Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population. Pharmacogenet Genomics (2008) 1.12
Vascular pharmacology of epoxyeicosatrienoic acids. Adv Pharmacol (2010) 1.11
Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics (2008) 1.09
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos (2002) 1.06
Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol (2008) 1.05
Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. Br J Clin Pharmacol (2001) 1.04
A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res (2012) 1.00
Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol (2009) 0.98
The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis. Arch Biochem Biophys (2009) 0.98
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver. PPAR Res (2010) 0.97
Identification of a novel rat microsomal vitamin D3 25-hydroxylase. J Biol Chem (2004) 0.97
Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol Ther (2012) 0.97
Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases. Steroids (2006) 0.96
Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2. Arch Biochem Biophys (2007) 0.96
Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions. Biochemistry (2001) 0.96
Regulation of mouse renal CYP2J5 expression by sex hormones. Mol Pharmacol (2004) 0.95
Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease. Trends Cardiovasc Med (2006) 0.95
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug Metab Dispos (2012) 0.93
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochem Pharmacol (2011) 0.92
Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos (2006) 0.90
Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. Br J Pharmacol (2000) 0.86
Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2. Mol Pharmacol (2010) 0.81
Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism. PLoS One (2010) 0.80
Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heart. Vascul Pharmacol (2012) 0.80
Utility of DPX2 cells for predicting CYP3A induction-mediated drug-drug interactions and associated structure-activity relationships. Drug Metab Dispos (2012) 0.79
Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Science (2000) 2.86
Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med (1966) 2.17
Retracted New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A (1998) 2.05
The domain structure and retrotransposition mechanism of R2 elements are conserved throughout arthropods. Mol Biol Evol (1999) 1.58
Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure. J Am Coll Surg (2002) 1.55
The teaching of medical ethics. J Med Ethics (1976) 1.51
Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg (2011) 1.49
Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions. Ann Thorac Surg (2009) 1.45
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures. Surg Gynecol Obstet (1975) 1.38
Laparoscopic cystectomy: initial report on a new treatment for the retained bladder. J Urol (1992) 1.35
Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics (2011) 1.34
Taxol biosynthesis and molecular genetics. Phytochem Rev (2006) 1.29
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo. Drug Metab Dispos (2011) 1.27
Fat embolism and osteonecrosis. Orthop Clin North Am (1985) 1.25
Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol Pharmacol (1999) 1.24
Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. Drug Metab Dispos (2004) 1.20
Stereochemical course of the biosynthesis of 1-aminocyclopropane-1-carboxylic acid. I. Role of the asymmetric sulfonium pole and the alpha-amino acid center. Biochem Biophys Res Commun (1984) 1.20
Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem (2001) 1.15
Treatment of trichomoniasis with a single dose of nimorazole (nitrimidazine). Br J Vener Dis (1972) 1.14
Osseous avascular necrosis associated with systemic abnormalities. Arthritis Rheum (1966) 1.11
Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. Drug Metab Dispos (2001) 1.11
Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos (2009) 1.10
Laparoscopic diverticulectomy: preliminary report of a new approach for the treatment of bladder diverticulum. J Urol (1992) 1.10
Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics (2008) 1.09
Assessment of barriers to bone marrow donation by unrelated African-American potential donors. Biol Blood Marrow Transplant (2001) 1.08
Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther (2006) 1.04
Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges. Brain Res Dev Brain Res (1996) 1.03
OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenet Genomics (2013) 1.02
Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun (1996) 1.01
Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding. Biochemistry (1999) 1.01
Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology. Expert Opin Drug Metab Toxicol (2009) 1.00
Intramolecular isotope effects for benzylic hydroxylation of isomeric xylenes and 4,4'-dimethylbiphenyl by cytochrome P450: relationship between distance of methyl groups and masking of the intrinsic isotope effect. Biochemistry (1997) 0.97
Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology (1997) 0.97
Focused ultrasound modifications of neural circuit activity in a mammalian brain. Ultrasound Med Biol (1998) 0.97
Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. J Am Coll Cardiol (2012) 0.97
Vitamin K-dependent carboxylation of peptide-bound glutamate. The active species of "CO2" utilized by the membrane-bound preprothrombin carboxylase. J Biol Chem (1977) 0.96
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics (2008) 0.95
Attenuation estimation in reflection: progress and prospects. Ultrason Imaging (1984) 0.95
Human liver expression of CYP2C8: gender, age, and genotype effects. Drug Metab Dispos (2010) 0.95
Modification by focused ultrasound pulses of electrically evoked responses from an in vitro hippocampal preparation. Brain Res (1991) 0.94
Regulation of skeletal muscle UCP-2 and UCP-3 gene expression by exercise and denervation. Am J Physiol (1999) 0.93
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug Metab Dispos (2012) 0.93
Formation of methyl sterols in brain cholesterol biosynthesis. Sterol formation in vitro in actively myelinating rat brain. J Biol Chem (1972) 0.93
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochem Pharmacol (2011) 0.92
Diffusion of the intravenous technique among narcotic addicts in the United States. J Health Soc Behav (1968) 0.91
Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch Biochem Biophys (1999) 0.91
Fat embolism of bone. A roentgenographic and histological investigation, with use of intra-arterial lipiodol, in rabbits. J Bone Joint Surg Am (1966) 0.91
Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics (1993) 0.90
Radionuclide stroke count ratios for assessment of right and left ventricular volume overload in children. Am J Cardiol (1983) 0.90
Violations of pesticide use and worker safety regulations in North Carolina. J Agric Saf Health (2007) 0.90
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant (2010) 0.90
Ribozyme-mediated revision of RNA and DNA. J Clin Invest (2003) 0.90
Design of a novel P450: a functional bacterial-human cytochrome P450 chimera. Biochemistry (1998) 0.89
Calcium-stimulated autophosphorylation site of plant chimeric calcium/calmodulin-dependent protein kinase. J Biol Chem (2001) 0.89
Effect of vitamin K homologues on the conversion of preprothrombin to prothrombin in rat liver microsomes. Biochem Biophys Res Commun (1976) 0.89
Mechanistic studies of uridine diphosphate glucuronosyltransferase. Chem Biol Interact (1994) 0.88
Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenet Genomics (2010) 0.85
Encoding processes and the recall of text. Mem Cognit (1983) 0.84
Purification and properties of chicken prothrombin. Arch Biochem Biophys (1974) 0.84
A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions. J Med Chem (2000) 0.83
Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide. J Med Chem (1995) 0.83
Total Artificial Heart as Bridge to Transplantation for Severe Culture-Negative Prosthetic Valve Endocarditis Due to Gemella haemolysans. ASAIO J (2015) 0.82
Structured long-range connections can provide a scaffold for orientation maps. J Neurosci (2000) 0.82
Low-dose digital computed radiography in pediatric chest imaging. AJR Am J Roentgenol (1988) 0.82
Scanning acoustic microscopy of neoplastic and inflammatory cutaneous tissue specimens. J Invest Dermatol (1991) 0.82
An assessment of the reaction energetics for cytochrome P450-mediated reactions. Arch Biochem Biophys (2001) 0.82
Receptive-field properties and laminar distribution of X-like and Y-like simple cells in cat area 17. J Neurophysiol (1984) 0.81
Cytochrome P450BM-3 reduces aldehydes to alcohols through a direct hydride transfer. Biochem Biophys Res Commun (2012) 0.81
Evaluation of cytochrome P450 mechanism and kinetics using kinetic deuterium isotope effects. Biochemistry (1998) 0.81
Osteonecrosis. Clin Orthop Relat Res (1978) 0.81
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screening. J Med Chem (2014) 0.80
Borderline necrosis of the femoral head. Clin Orthop Relat Res (1999) 0.80
Benign synthesis of 2-ethylhexanoic acid by cytochrome P450cam: enzymatic, crystallographic, and theoretical studies. Biochemistry (2001) 0.80
Performance and macrokinetic analysis of biofiltration of toluene and p-xylene mixtures in a conventional biofilter packed with inert material. Bioresour Technol (2011) 0.80
Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences. Biochem Biophys Res Commun (2012) 0.80
Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394. Biochemistry (2000) 0.79
Stereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion. Drug Metab Dispos (1995) 0.79
Inexpensive purification of P450 reductase and other proteins using 2',5'-adenosine diphosphate agarose affinity columns. Protein Expr Purif (2001) 0.79
Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Chem Res Toxicol (1992) 0.79
Laparoscopic intraperitoneal marsupialization: report on a new treatment for lymphoceles. Surg Laparosc Endosc (1992) 0.79
Nature of the vitamin K-dependent CO2 fixation in microsomal membranes. Fed Proc (1978) 0.79
Radionuclide ventriculography for assessment of absolute right and left ventricular volumes in children. Circulation (1982) 0.78
Epidemiological study of coronary disease risk factors. I. Study design and characteristics of individual study subjects. Am J Epidemiol (1968) 0.78
The biosynthesis of cholesterol and other sterols by brain tissue. II. A comparison of in vitro and in vivo methods. Lipids (1971) 0.78
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer. Ann Surg Oncol (2005) 0.78
Insulin-induced hypoglycemia in fed and fasted exercising rats. J Appl Physiol (1985) (1992) 0.78
Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes. Proc Natl Acad Sci U S A (1995) 0.78
Isolation and characterization of isoprothrombin in the rat. Biochem Biophys Res Commun (1973) 0.78
Percutaneous coronary sinus catheterization for minimally invasive cardiac surgery--more questions than answers? J Cardiothorac Vasc Anesth (2010) 0.78
Alcoholism, hypercortisonism, fat embolism and osseous avascular necrosis. 1971. Clin Orthop Relat Res (2001) 0.78